Company or ticker...

CG Oncology

CG Oncology develops bladder cancer therapies, including oncolytic immunotherapy.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

CGON

6.7B

1,331.6

n/a

84.00%

Key Facts

M. Cap

PS

PE

YTD

6.7B

1,331.6

n/a

84.00%

10MA

20MA

50MA

200MA

$CGON